SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NICE Guidance for IMCIVREE Updated to Include Adults With Bardet-Biedl Syndrome

Rhythm Pharmaceuticals says updated NICE guidance includes adults living with Bardet-Biedl syndrome, based on additional evidence of IMCIVREE’s benefits in adults.

RYTM

Related stories